Supplement: CRISPR screens of population relevant genes governing toxicant resilience

补充:CRISPR 筛选控制毒物抵抗力的群体相关基因

基本信息

  • 批准号:
    10720972
  • 负责人:
  • 金额:
    $ 36.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-02-14 至 2026-11-30
  • 项目状态:
    未结题

项目摘要

Summary The goal of this supplement is to enhance diversity in the research workforce through support of a disabled graduate student in response to PA-21-071(Research Supplement to Promote Diversity in Health-Related Research). This supplement will enable the disabled student to work in the laboratory of the PI of parent grant by providing support for his stipend and tuition, as well as allowing the hiring of a dedicated technical research assistant for the components of the proposed work requiring fine motor capabilities. In addition, mentorship, career development support, targeted training efforts, and reasonable accommodations will enable the student to continue to pursue a scientific career while navigating the challenges presented by his disability. The parent grant focuses on GXE interactions with exogenous stressors but posited application to GXE interactions with endogenous stressors, such as a pre-existing monogenic genetic disorder, which is the focus of the supplement. We selected the monogenic disorder, Friedrich’s ataxia (FRDA), a progressive neurodegenerative disorder most commonly due to triplet repeat mutations in the frataxin gene. While triplet repeat length plays a role in the disease presentation, other unknown genetic and environmental factors clearly contribute. We will assess the capability of our novel targeted functional screening approach to identify genes which when disrupted could modulate the cellular phenotype of FRDA. As with the parent grant, the work will focus on the set of ~1490 genes with common LOF mutations in the population and will assess functional effect by assessing changes in the transcriptional phenotype of relevant cells. This work if successful could provide important insight into common LOF variants that impact the presentation and progression of Friedrich’s ataxia. This functional screening approach using transcriptional phenotypic endpoints could have general applicability to any genetic disease and enable identification of potentially functionally significant and population relevant genetic variants impacting the phenotypic manifestations of the disease.
概括 该增刊的目标是通过支持残疾人来增强研究队伍的多样性 研究生回应 PA-21-071(促进健康相关多样性的研究补充 研究)。该补助金将使残疾学生能够在家长资助的 PI 实验室工作 通过为他的津贴和学费提供支持,以及允许雇用专门的技术研究人员 助理负责拟议工作中需要精细运动能力的部分。此外,辅导、 职业发展支持、有针对性的培训工作和合理的住宿将使学生能够 继续追求科学事业,同时应对残疾带来的挑战。家长 拨款重点关注 GXE 与外源压力源的相互作用,但提出了 GXE 与 内源性压力源,例如预先存在的单基因遗传性疾病,这是补充剂的重点。 我们选择了单基因疾病弗里德里希共济失调 (FRDA),这是一种最常见的进行性神经退行性疾病。 通常是由于 frataxin 基因中的三联体重复突变所致。虽然三联体重复长度在 疾病表现、其他未知的遗传和环境因素显然有影响。我们将评估 我们新颖的靶向功能筛选方法能够识别基因,这些基因在被破坏时可以 调节 FRDA 的细胞表型。与家长资助一样,这项工作将集中在 ~1490 人群中具有常见 LOF 突变的基因,并将通过评估基因的变化来评估功能效果 相关细胞的转录表型。这项工作如果成功的话可以提供重要的见解 影响弗里德里希共济失调表现和进展的常见 LOF 变异。这个功能性的 使用转录表型终点的筛选方法可以普遍适用于任何遗传 疾病并能够识别具有潜在功能意义和群体相关的遗传变异 影响疾病的表型表现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER D VULPE其他文献

CHRISTOPHER D VULPE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER D VULPE', 18)}}的其他基金

CRISPR screens of population relevant genes governing toxicant resilience
CRISPR 筛选控制毒物抵抗力的群体相关基因
  • 批准号:
    10337726
  • 财政年份:
    2022
  • 资助金额:
    $ 36.64万
  • 项目类别:
CRISPR screens of population relevant genes governing toxicant resilience
CRISPR 筛选控制毒物抵抗力的群体相关基因
  • 批准号:
    10573193
  • 财政年份:
    2022
  • 资助金额:
    $ 36.64万
  • 项目类别:
Functional Profiling to Identify Mitochondria-cell Signaling Networks
识别线粒体细胞信号网络的功能分析
  • 批准号:
    9068923
  • 财政年份:
    2015
  • 资助金额:
    $ 36.64万
  • 项目类别:
An integrated molecular approach to understand variation in iron metabolism
了解铁代谢变化的综合分子方法
  • 批准号:
    8669002
  • 财政年份:
    2012
  • 资助金额:
    $ 36.64万
  • 项目类别:
An integrated molecular approach to understand variation in iron metabolism
了解铁代谢变化的综合分子方法
  • 批准号:
    8885844
  • 财政年份:
    2012
  • 资助金额:
    $ 36.64万
  • 项目类别:
An integrated molecular approach to understand variation in iron metabolism
了解铁代谢变化的综合分子方法
  • 批准号:
    8238272
  • 财政年份:
    2012
  • 资助金额:
    $ 36.64万
  • 项目类别:
An integrated molecular approach to understand variation in iron metabolism
了解铁代谢变化的综合分子方法
  • 批准号:
    8501536
  • 财政年份:
    2012
  • 资助金额:
    $ 36.64万
  • 项目类别:
Project 2: Functional Profiling of Susceptibility Genes
项目2:易感基因的功能分析
  • 批准号:
    8063132
  • 财政年份:
    2010
  • 资助金额:
    $ 36.64万
  • 项目类别:
Integrated nanoparticle characterizaton and toxicity assessment
综合纳米颗粒表征和毒性评估
  • 批准号:
    7939794
  • 财政年份:
    2009
  • 资助金额:
    $ 36.64万
  • 项目类别:
Integrated nanoparticle characterizaton and toxicity assessment
综合纳米颗粒表征和毒性评估
  • 批准号:
    7854985
  • 财政年份:
    2009
  • 资助金额:
    $ 36.64万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 36.64万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 36.64万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 36.64万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 36.64万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 36.64万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 36.64万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 36.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 36.64万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 36.64万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 36.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了